Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Vignir Helgason

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Autophagy|March 1, 2022
Targeting ULK1 in cancer stem cells: insight from chronic myeloid leukemiaAngela Ianniciello, G Vignir Helgason
Immunological Reviews|December 17, 2014
Do we need more drugs for chronic myeloid leukemia?Tessa L Holyoake, G Vignir Helgason
Nature Reviews. Cancer|January 8, 2020
The leukaemia stem cell: similarities, differences and clinical prospects in CML and AMLDavid Vetrie, G Vignir Helgason, Mhairi Copland
Leukemia|March 12, 2021
Folate metabolism: a re-emerging therapeutic target in haematological cancersMartha M Zarou, Alexei Vazquez, G Vignir Helgason
Frontiers in Cell and Developmental Biology|October 16, 2018
The Ins and Outs of Autophagy and Metabolism in Hematopoietic and Leukemic Stem Cells: Food for ThoughtAngela Ianniciello, Kevin M Rattigan, G Vignir Helgason
Blood|June 23, 2011
Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CMLG Vignir Helgason, Maria Karvela, Tessa L Holyoake
Leukemia|September 25, 2021
Mitochondrial metabolism as a potential therapeutic target in myeloid leukaemiaLucie de Beauchamp, Ekaterini Himonas, G Vignir Helgason
Cancer Research|May 13, 2010
Oncogene-induced sensitization to chemotherapy-induced death requires induction as well as deregulation of E2F1G Vignir Helgason, Jim O'Prey, Kevin M Ryan
Expert Review of Anticancer Therapy|February 29, 2012
Mechanisms and novel approaches in overriding tyrosine kinase inhibitor resistance in chronic myeloid leukemiaMaria Karvela, G Vignir Helgason, Tessa L Holyoake
Blood|January 12, 2023
Metabolism in stem cell-driven leukemia: parallels between hematopoiesis and immunityKevin M Rattigan, Martha M Zarou, G Vignir Helgason
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Autophagy|March 1, 2022
Targeting ULK1 in cancer stem cells: insight from chronic myeloid leukemiaAngela Ianniciello, G Vignir Helgason
Immunological Reviews|December 17, 2014
Do we need more drugs for chronic myeloid leukemia?Tessa L Holyoake, G Vignir Helgason
Nature Reviews. Cancer|January 8, 2020
The leukaemia stem cell: similarities, differences and clinical prospects in CML and AMLDavid Vetrie, G Vignir Helgason, Mhairi Copland
Leukemia|March 12, 2021
Folate metabolism: a re-emerging therapeutic target in haematological cancersMartha M Zarou, Alexei Vazquez, G Vignir Helgason
Frontiers in Cell and Developmental Biology|October 16, 2018
The Ins and Outs of Autophagy and Metabolism in Hematopoietic and Leukemic Stem Cells: Food for ThoughtAngela Ianniciello, Kevin M Rattigan, G Vignir Helgason
Blood|June 23, 2011
Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CMLG Vignir Helgason, Maria Karvela, Tessa L Holyoake
Leukemia|September 25, 2021
Mitochondrial metabolism as a potential therapeutic target in myeloid leukaemiaLucie de Beauchamp, Ekaterini Himonas, G Vignir Helgason
Cancer Research|May 13, 2010
Oncogene-induced sensitization to chemotherapy-induced death requires induction as well as deregulation of E2F1G Vignir Helgason, Jim O'Prey, Kevin M Ryan
Expert Review of Anticancer Therapy|February 29, 2012
Mechanisms and novel approaches in overriding tyrosine kinase inhibitor resistance in chronic myeloid leukemiaMaria Karvela, G Vignir Helgason, Tessa L Holyoake
Blood|January 12, 2023
Metabolism in stem cell-driven leukemia: parallels between hematopoiesis and immunityKevin M Rattigan, Martha M Zarou, G Vignir Helgason
Pageof 4